- Home
- SLGL vs NAUT Comparison
SLGL vs NAUT Comparison
Compare SLGL & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLGL | NAUT |
|---|---|---|
| Founded | 1997 | 2016 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.9M | 218.6M |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLGL | NAUT |
|---|---|---|
| Price | $87.40 | $0.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $110.00 | $4.00 |
| AVG Volume (30 Days) | 31.9K | ★ 949.0K |
| Earning Date | 05-22-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $223.84 | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.20 | $0.62 |
| 52 Week High | $97.97 | $4.31 |
Technical Indicators
Market Signals| Indicator | SLGL | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 61.84 | 20.62 |
| Support Level | $67.53 | N/A |
| Resistance Level | $95.31 | $2.30 |
| Average True Range (ATR) | 6.62 | 0.13 |
| MACD | 0.30 | -0.05 |
| Stochastic Oscillator | 68.39 | 0.91 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.